Cargando…
Metabolic syndrome and benign prostatic hyperplasia: An update
Metabolic syndrome (MetS) is a cluster of metabolic abnormalities related to central adiposity and insulin resistance. Its importance is increasingly recognized as it associates with increased risks of metabolic and cardiovascular diseases. These metabolic aberrations of MetS may lead to development...
Autores principales: | Ngai, Ho-Yin, Yuen, Kar-Kei Steffi, Ng, Chi-Man, Cheng, Cheung-Hing, Chu, Sau-Kwan Peggy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717972/ https://www.ncbi.nlm.nih.gov/pubmed/29264226 http://dx.doi.org/10.1016/j.ajur.2017.05.001 |
Ejemplares similares
-
Update on minimally invasive surgery and benign prostatic hyperplasia
por: Chung, Amanda S.J., et al.
Publicado: (2018) -
Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018) -
An Update on the Outcomes of Patients Treated with Urolift for Benign Prostatic Hyperplasia
por: Loloi, Justin, et al.
Publicado: (2021) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
Various treatment options for benign prostatic hyperplasia: A current update
por: Shrivastava, Alankar, et al.
Publicado: (2012)